3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Oral Glucose Tolerance Test: new trials by email Literature Review of Oral Glucose Tolerance Test trials Research Report on Oral Glucose Tolerance Test
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test Oral Glucose Tolerance Test, Kisspeptin, Placebo - Metabolic Diseases | Phase 1 | Completed | Massachusetts General Hospital | 16 | 2021-10-28 | 2026-03-06 |
| Mechanisms of Cerebrovascular Control NOS Inhibition, ET-1 Inhibition, NOS Inhibition Placebo - Metabolic Syndrome X | Phase 1 | Completed | University of Wisconsin, Madison | 59 | 2017-01-31 | 2021-10-18 |
| Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans Glipizide, Metformin, Oral Glucose Tolerance Test - Diabetes Mellitus, Type 2 | Phase 1 | Completed | Massachusetts General Hospital | 1033 | 2008-01-01 | 2026-05-06 |
Aneurysm (1) · Diabetes Mellitus, Type 2 (1) · Insulin Resistance (1) · Metabolic Diseases (1) · Metabolic Syndrome (1) · Obesity (1)
Massachusetts General Hospital (2) · University of Wisconsin, Madison (1)
United States (3)
Jose C Florez, MD, PhD (1) · Margaret Lippincott, MD (1) · William G. Schrage, Ph.D. (1)
PMID 25812009, PMID 29326107, PMID 31709648
K23HD097296 (1)